Khaberni - A recent study found that taking a low dose of the drug "Colchicine," used for treating gout, may help prevent heart attacks and strokes in patients with cardiovascular disease.
"Colchicine" is typically prescribed to relieve pain and inflammation associated with gout.
According to "Medical News Today," the study included a review and analysis of data from 12 previous studies involving 23,000 people, focusing on the impact of the drug's low dosage, which is known for its anti-inflammatory properties.
The analysis focused on those who had recently suffered a heart attack or stroke, or who already had stable cardiovascular diseases.
Low dose
The researchers found that a low dose of "Colchicine" helps reduce the risk of heart attacks and strokes, identifying another potential strategy to help prevent these conditions.
The research team from the University of Greifswald in Germany and the University Hospital Basel in Switzerland also found strong evidence that "Colchicine" does not increase the likelihood of experiencing serious side effects.
However, the results also indicated that its intake is associated with some gastrointestinal side effects such as nausea, but these effects are mild and do not last long.
Addition to secondary preventive medications
The researchers said: "Colchicine represents one of the most impactful additions to the toolkit of secondary prevention since high-intensity statins."
They added: "Its ability to reduce myocardial infarction/heart attacks and strokes - in addition to modern lipid-lowering treatment - makes it a practical, evidence-based option for physicians treating patients with a remaining high inflammatory risk."
